V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280003615 | 280002686 | 1.65 | 92.3 | Neo-adjuvant (N) | 2015-04-02 | 2015-04-02 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | null | 280025855 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003616 | 280002687 | 1.83 | 68.4 | Neo-adjuvant (N) | 2017-11-26 | 2017-12-03 | Doxorubicin + Ifosfamide | N | N | 280025860 | DOXORUBICIN + IFOSFAMIDE |
| 280003617 | 280002688 | 1.61 | 86 | Neo-adjuvant (N) | 2013-03-19 | 2015-05-26 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025861 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003618 | 280002689 | 1.81 | 62.8 | Curative (C) | 2015-02-09 | 2015-02-09 | Cetuximab + Radiotherapy Load | N | N | 280025864 | CETUXIMAB + RT |
| 280003619 | 280002689 | null | 52.1 | Neo-adjuvant (N) | 2016-06-10 | 2016-06-11 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 280025864 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003620 | 280002689 | 1.63 | 44.5 | Neo-adjuvant (N) | 2015-06-27 | 2015-07-22 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025864 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003621 | 280010933 | 1.74 | 108 | Neo-adjuvant (N) | 2017-05-10 | 2017-05-10 | Cisplatin + Docetaxel +Fluorouracil | null | null | 280025870 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003622 | 280010933 | 1.81 | 68 | Palliative (P) | 2017-07-11 | 2017-07-24 | Doxorubicin + Ifosfamide | N | N | 280025870 | DOXORUBICIN + IFOSFAMIDE |
| 280003623 | 280002690 | null | 58.4 | Neo-adjuvant (N) | null | 2017-09-24 | Cisplatin +Fluorouracil (3 wk) | null | null | 280025873 | CISPLATIN + FLUOROURACIL |
| 280003624 | 280002691 | 1.67 | 68.1 | Neo-adjuvant (N) | null | 2016-04-26 | Cisplatin + Docetaxel +Fluorouracil | null | null | 280025874 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003625 | 280002692 | 1.71 | 60 | Neo-adjuvant (N) | 2017-02-26 | 2017-03-03 | Cisplatin + Docetaxel +Fluorouracil | null | null | 280025875 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003626 | 280002693 | 1.6 | 130 | Disease modification (D) | 2013-12-17 | 2013-12-23 | Doxorubicin + Ifosfamide | N | N | 280025877 | DOXORUBICIN + IFOSFAMIDE |
| 280003627 | 280002693 | 1.69 | 68.4 | null | 2015-09-19 | 2015-10-04 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | N | 280025877 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003628 | 280002693 | 0 | 70 | Neo-adjuvant (N) | 2018-01-06 | 2018-01-06 | Doxorubicin + Ifosfamide | 02 | null | 280025877 | DOXORUBICIN + IFOSFAMIDE |
| 280003630 | 280002694 | 1.77 | 96 | Neo-adjuvant (N) | 2018-03-11 | 2018-03-27 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 280025883 | CISPLATIN + FLUOROURACIL |
| 280003631 | 280002695 | 1.7 | 91.9 | Curative (C) | 2015-04-26 | 2015-05-06 | Cetuximab + Radiotherapy Load | 02 | null | 280025885 | CETUXIMAB + RT |
| 280003632 | 280002696 | 1.63 | 74.2 | Neo-adjuvant (N) | 2013-10-05 | 2013-10-10 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 280025887 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003633 | 280002697 | 1.7 | 88.7 | Neo-adjuvant (N) | 2013-06-03 | 2013-06-24 | Doxorubicin + Ifosfamide | Y | N | 280025889 | DOXORUBICIN + IFOSFAMIDE |
| 280003634 | 280002698 | 1.79 | 78 | Neo-adjuvant (N) | 2014-06-05 | 2014-06-06 | Doxorubicin + Ifosfamide | 02 | N | 280025890 | DOXORUBICIN + IFOSFAMIDE |
| 280003635 | 280002699 | 1.71 | 96 | Palliative (P) | 2015-03-11 | 2015-03-25 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 280025892 | CISPLATIN + FLUOROURACIL |
| 280003636 | 280002700 | 1.79 | 123 | Neo-adjuvant (N) | 2016-01-03 | 2016-01-09 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 280025893 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003637 | 280002701 | 1.74 | 93.6 | Disease modification (D) | 2013-04-12 | 2013-04-25 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 280025897 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003638 | 280002702 | null | null | Neo-adjuvant (N) | 2013-02-03 | 2013-02-08 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 280025898 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003639 | 280002702 | 1.98 | 104 | Adjuvant (A) | 2014-05-27 | 2014-05-28 | DOXORUBICIN + IFOSFAMIDE | N | N | 280025898 | DOXORUBICIN + IFOSFAMIDE |
| 280003640 | 280002702 | 1.67 | null | Palliative (P) | 2015-06-18 | 2015-06-18 | Doxorubicin + Ifosfamide | null | null | 280025898 | DOXORUBICIN + IFOSFAMIDE |
| 280003641 | 280002703 | 1.77 | 64.5 | Neo-adjuvant (N) | 2017-10-07 | 2017-10-19 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 280025903 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003642 | 280002703 | 1.67 | 96 | Palliative (P) | 2017-11-08 | 2017-11-29 | Doxorubicin + Ifosfamide | N | N | 280025903 | DOXORUBICIN + IFOSFAMIDE |
| 280003643 | 280002703 | 1.77 | 70 | null | 2017-12-27 | 2018-01-15 | Cetuximab + Radiotherapy Load | N | Y | 280025903 | CETUXIMAB + RT |
| 280003644 | 280002704 | 1.85 | 73.3 | null | 2014-04-10 | 2014-04-10 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 280025907 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003645 | 280002705 | 1.51 | 117.2 | null | 2016-06-12 | 2016-07-02 | Cisplatin +Fluorouracil (3 wk) | 2 | N | 280025910 | CISPLATIN + FLUOROURACIL |
| 280003646 | 280002706 | 1.65 | 65.9 | Neo-adjuvant (N) | 2016-03-06 | 2016-03-23 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280025913 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003647 | 280002707 | 1.72 | 74 | Palliative (P) | 2016-03-03 | 2016-03-27 | Cisplatin +Fluorouracil (3 wk) | 2 | null | 280025915 | CISPLATIN + FLUOROURACIL |
| 280003648 | 280002708 | 1.9 | 68.8 | Neo-adjuvant (N) | 2017-08-02 | 2017-08-16 | CISPLATIN + FLUOROURACIL | 2 | N | 280025916 | CISPLATIN + FLUOROURACIL |
| 280003649 | 280002708 | 1.84 | 57.4 | Curative (C) | 2013-06-20 | 2013-07-13 | CETUXIMAB + RT | N | N | 280025916 | CETUXIMAB + RT |
| 280003650 | 280002709 | 1.83 | 98 | Curative (C) | 2013-11-03 | 2013-11-12 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 280025918 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003651 | 280002710 | 1.55 | 75.7 | Neo-adjuvant (N) | 2017-11-09 | 2017-11-13 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 280025920 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003652 | 280002710 | 1.69 | 107 | Neo-adjuvant (N) | null | 2013-03-02 | Cisplatin +Fluorouracil (3 wk) | null | null | 280025920 | CISPLATIN + FLUOROURACIL |
| 280003653 | 280009749 | 1.82 | 122 | Curative (C) | 2016-03-04 | 2016-03-10 | Cetuximab + Radiotherapy Maint | 02 | null | 280025924 | CETUXIMAB + RT |
| 280003654 | 280002711 | 1.9 | 89 | Curative (C) | 2017-02-26 | 2017-03-05 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | N | 280025928 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003655 | 280002712 | 1.8 | 61 | Curative (C) | 2016-07-26 | 2016-07-27 | CISPLATIN + FLUOROURACIL | 02 | N | 280025931 | CISPLATIN + FLUOROURACIL |
| 280003656 | 280002713 | 1.77 | 63 | null | 2016-12-01 | 2016-12-05 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 280025932 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003657 | 280002714 | 1.83 | 54.3 | Palliative (P) | 2017-08-04 | 2017-08-11 | Doxorubicin + Ifosfamide | 02 | N | 280025933 | DOXORUBICIN + IFOSFAMIDE |
| 280003658 | 280007346 | 1.58 | 77 | Curative (C) | 2014-02-01 | 2014-02-21 | CETUXIMAB + RT | N | Y | 280025934 | CETUXIMAB + RT |
| 280003659 | 280002715 | 1.75 | 78.5 | Neo-adjuvant (N) | 2014-08-28 | 2014-09-05 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 280025935 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003660 | 280002716 | 1.58 | 114 | Curative (C) | 2017-05-04 | 2017-05-18 | CETUXIMAB + RT | N | Y | 280025936 | CETUXIMAB + RT |
| 280003661 | 280002717 | 1.64 | 95 | Curative (C) | 2016-02-13 | 2016-03-22 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | null | 280025938 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003662 | 280002717 | 1.76 | 105.4 | Curative (C) | 2017-02-03 | 2017-02-04 | CETUXIMAB + RT | null | null | 280025938 | CETUXIMAB + RT |
| 280003663 | 280002717 | 1.68 | 55.4 | Curative (C) | 2015-02-16 | 2015-02-16 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 280025938 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003664 | 280002718 | 1.82 | 72.9 | Neo-adjuvant (N) | 2015-04-20 | 2015-04-28 | DOXORUBICIN + IFOSFAMIDE | N | N | 280025944 | DOXORUBICIN + IFOSFAMIDE |
| 280003665 | 280002719 | 1.65 | 77.9 | null | 2014-11-24 | 2014-12-25 | Doxorubicin + Ifosfamide | 2 | null | 280025945 | DOXORUBICIN + IFOSFAMIDE |